
Nov 19 (Reuters) – Dicot Pharma AB: * RECEIVES EU APPROVAL FOR PHASE 2B STUDY OF LIB-01 Source text: Further company coverage: (Gdansk Newsroom)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Anthropic's historic debut to put AI's promise and peril to Wall St test
By Niket Nishant, Manya Saini and Echo Wang Nov 19 (Reuters) - Anthropic's record $81…
Walmart nudges up annual forecasts ahead of crucial holiday season
Nov 19 (Reuters) - Walmart slightly raised its annual targets on Thursday, betting that demand…
Gujarat to host delegates from 15 countries as Global Potato Summit 2026 on December 16–17…